Stay updated on Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.

Latest updates to the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added to the page history, and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check13 days agoChange DetectedDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision v3.4.2 to the record history and removed the old government-funding notice and revision v3.4.1.SummaryDifference0.2%

- Check42 days agoChange DetectedA government funding lapse notice is displayed on the page, clarifying possible data delays and NIH Clinical Center status, and the page revision label has been updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe history page now includes a Show glossary toggle, color-coded highlights for additions (green) and deletions (red) in the diffs, and an updated Revision: v3.4.0 label.SummaryDifference0.3%

- Check85 days agoChange DetectedA new revision entry (v3.3.3) was added and the old revision (v3.3.2) plus the HHS Vulnerability Disclosure link were removed. These are minor metadata updates that do not affect the study record content.SummaryDifference0.1%

Stay in the know with updates to Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.